FemTouch™ - Laser Vaginal Rejuvenation


FemTouch™ for improved vaginal health

FemTouch™, a new solution for treatment of vaginal health related conditions.

FemTouch™ is a vaginal laser that addresses vaginal health related conditions by promoting the remodelling of the vaginal mucous epithelium layer. The CO₂ fractional laser is applied along the vaginal wall which results in very gentle controlled ablation an coagulation of the vaginal lining.

The FemTouch™ gynaecology laser solution was developed by Lumenis, the inventor of CO₂ technology, combining a heritage in gynaecology applications. For over two decades, gynaecologists around the world have been using Lumenis’ CO₂ products to perform various surgeries such as vaginal, robotic and laparoscopic procedures. FemTouch™ has been developed in collaboration with leading gynaecologists in the field.

The Need

With age and after childbirth, women start noticing symptoms related to their vaginal health that affect their lifestyle on different levels. Vaginal atrophy or dryness is a common symptom in post menopausal women that is sometimes accompanied by itching or pain regularly and also during sexual intercourse.

Stress urinary incontinence is another symptom appearing also in a younger demographic, in some cases already for women 20-45 years old. Women who have undergone childbirth will often notice symptoms of vaginal laxity which can impact their satisfaction with sexual intercourse.

The Solution: A Simple, Fast And Comfortable In Office Procedure

  • Fast – The procedure takes only a couple of minutes.
  • Efficient – Only 2-4 treatments are needed for optimal outcomes.
  • HassleFree – No anaesthesia nor special post-procedure care are required.

Clinical Evidence

* porcine ex-vivo model

Vaginoscopy of the posterior wall – Courtesy of Massimiliano Marziali MD.

FemTouch™ vaginal laser treatment from Lumenis on Vimeo.

References:

¹ Urinary Incontinence in US Women, A Population Based Study. Arch Intern Med. 2005.
² Management of symptomatic vulvovaginal atrophy: 2013 position statement of The North American Menopause Society.